Population
Patients with or recovering from neuroleptic malignant syndrome
Design
Review
Key result
Neuroleptic malignant syndrome is a potentially lethal, underdiagnosed idiosyncratic reaction to neuroleptic agents that requires early recognition and specific treatments to decrease morbidity and mortality.
Authors
Loading...
This review summarizes the major features, supportive therapy, and investigational treatments for neuroleptic malignant syndrome, along with guidelines for restarting neuroleptic therapy.
This review summarizes the major features, supportive therapy, and investigational treatments for neuroleptic malignant syndrome, along with guidelines for restarting neuroleptic therapy.
Lavie et al. (1986) conducted a review in Neuroleptic malignant syndrome. Supportive therapy and investigational treatments (anticholinergics, muscle relaxants, dopamine agonists) was evaluated. Neuroleptic malignant syndrome is a potentially lethal, underdiagnosed idiosyncratic reaction to neuroleptic agents that requires early recognition and specific treatments to decrease morbidity and mortality.